Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.47
+0.06200.18%
Post-market: 34.46-0.0120-0.03%19:30 EDT
Volume:17.43K
Turnover:602.34K
Market Cap:95.83M
PE:- -
High:34.93
Open:34.93
Low:34.46
Close:34.41
52wk High:36.84
52wk Low:23.42
Shares:2.78M
Float Shares:2.78M
Volume Ratio:0.82
T/O Rate:0.63%
Dividend:0.26
Dividend Rate:0.75%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment

Stock News
·
Sep 02

Political and General News Events from September 2

Reuters
·
Sep 02

uniQure seeks accelerated approval for Huntington’s gene therapy

TIPRANKS
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Sep 02

Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets

Stock News
·
Sep 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 02

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Sep 02

Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts

Deep News
·
Sep 02

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Reuters
·
Sep 02

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Sep 02

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01

Reuters
·
Sep 01

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS
·
Sep 01

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire
·
Sep 01